Ethics and accountability for clinical trials

Area of Science:

• Biomedical Research
• Clinical Trial Registries
• Data Integrity

Background:

• ClinicalTrials.gov is a primary resource for clinical trial information.
• A May 2023 disclaimer raises concerns about data accuracy and accountability.
• Spinal cord injury research relies on accurate and accessible trial data.

Purpose of the Study:

• To highlight critical data integrity issues on ClinicalTrials.gov.
• To assess the risks posed by inaccurate information in spinal cord injury trials.
• To advocate for improvements in the ClinicalTrials.gov database.

Main Methods:

• Analysis of ClinicalTrials.gov disclaimer and its implications.
• Examination of data inconsistencies in spinal cord injury trial registrations.
• Review of the impact on regulatory use and participant decision-making.

Main Results:

• ClinicalTrials.gov disclaimed accountability for registered information accuracy.
• Inconsistencies were identified in intervention classification and phase designation for spinal cord injury studies.
• Lack of publicly available study protocols and results was noted.

Conclusions:

• Data inaccuracies on ClinicalTrials.gov pose risks to users and research integrity.
• Improvements are needed to ensure the reliability of ClinicalTrials.gov for spinal cord injury research.
• Investing in the database's authority is essential for regulatory compliance and informed decision-making.